<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药时代 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-11T07:35:48+08:00</updated>
  <subtitle>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>降糖“潜力股”，礼来GIP / GLP-1双重激动剂显著降低2型糖尿病患者血糖水平和体重</title>
    <updated>2020-12-11T06:59:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/kOW_8ut7a_Db4InJUySpsQ</id>
    <link href="https://mp.weixin.qq.com/s/kOW_8ut7a_Db4InJUySpsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代知识宝库｜火热双12，一起充电，全力迎接2021年！</title>
    <updated>2020-12-11T06:59:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/GrG_LS3Lvnmg7d0ZwmhzLQ</id>
    <link href="https://mp.weixin.qq.com/s/GrG_LS3Lvnmg7d0ZwmhzLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>​Tavotek专注于肿瘤与免疫疾病的新药研发</title>
    <updated>2020-12-11T06:59:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/_dhz0OJXQlSDCqbijsCHSw</id>
    <link href="https://mp.weixin.qq.com/s/_dhz0OJXQlSDCqbijsCHSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>氰基(-CN)结构是如何提高药物分子活性的？</title>
    <updated>2020-12-11T06:59:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/LzGSF3AoTJCTDYBgWNHW5g</id>
    <link href="https://mp.weixin.qq.com/s/LzGSF3AoTJCTDYBgWNHW5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FLT3抑制剂治疗AML研究进展</title>
    <updated>2020-12-11T06:59:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/YtmKUeQLebwxJzI4QrDx9w</id>
    <link href="https://mp.weixin.qq.com/s/YtmKUeQLebwxJzI4QrDx9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代诚聘英才，居家办公，共筑健康天下！</title>
    <updated>2020-12-11T06:59:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/Vuv_s5WbX4q04HyOy4oEwg</id>
    <link href="https://mp.weixin.qq.com/s/Vuv_s5WbX4q04HyOy4oEwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH｜礼来公布BRUIN临床试验数据，LOXO-305能否在BTK抑制剂中脱颖而出，抢占Ibrutinib市场？</title>
    <updated>2020-12-10T08:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/0Df1btwTO_wOCpChJIsRoQ</id>
    <link href="https://mp.weixin.qq.com/s/0Df1btwTO_wOCpChJIsRoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国科学院上海药物研究所与华为云签署创新合作协议</title>
    <updated>2020-12-10T08:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/JsvS_0fb63WVr6mhegCpkA</id>
    <link href="https://mp.weixin.qq.com/s/JsvS_0fb63WVr6mhegCpkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今晚7点，高光博士、吴稚伟教授和李佳博士深度解读“疫苗竞赛”</title>
    <updated>2020-12-10T08:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/OdFE6jQKIbP-nhkpoqUqvA</id>
    <link href="https://mp.weixin.qq.com/s/OdFE6jQKIbP-nhkpoqUqvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年生物制药交易分析：疫情之下收购有所突破</title>
    <updated>2020-12-10T08:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/QtaAOpAqndQGSfQtuTzF9g</id>
    <link href="https://mp.weixin.qq.com/s/QtaAOpAqndQGSfQtuTzF9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>补体抑制剂迎来最强竞争者</title>
    <updated>2020-12-10T08:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/_sQQi4MaUZ065ybFbF4uyA</id>
    <link href="https://mp.weixin.qq.com/s/_sQQi4MaUZ065ybFbF4uyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博腾药时代直播间 | 新药开发过程中的CMC一体化项目管理的分享</title>
    <updated>2020-12-10T08:20:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/DC-Y9fO_b2XpniejJfPtGw</id>
    <link href="https://mp.weixin.qq.com/s/DC-Y9fO_b2XpniejJfPtGw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH | 三年过去了，历史上第一个获批的CAR-T疗法Kymriah如今有何进展？</title>
    <updated>2020-12-09T08:12:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/jwa4HlmTtuub6-OlQ3c0yQ</id>
    <link href="https://mp.weixin.qq.com/s/jwa4HlmTtuub6-OlQ3c0yQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药与Applied BioMath, LLC启动肿瘤领域系统药理学建模的战略合作</title>
    <updated>2020-12-09T08:12:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/vMILr5rlgJicmZ4Ysc6DDg</id>
    <link href="https://mp.weixin.qq.com/s/vMILr5rlgJicmZ4Ysc6DDg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>思南峰会系列分享之“疫苗竞赛”</title>
    <updated>2020-12-09T08:12:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/kS21by4a9iFVJlRv29BE1A</id>
    <link href="https://mp.weixin.qq.com/s/kS21by4a9iFVJlRv29BE1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cell子刊：新冠病毒是如何劫持并摧毁人类肺部细胞的</title>
    <updated>2020-12-09T08:12:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/EBN16DrhQItOwJtb0CujtQ</id>
    <link href="https://mp.weixin.qq.com/s/EBN16DrhQItOwJtb0CujtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代招聘 | 如果华为“在一起，就可以！”，那么“药时代，一起来！”</title>
    <updated>2020-12-09T08:12:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/ZXVWlAMrCNR2o7_MUekCjQ</id>
    <link href="https://mp.weixin.qq.com/s/ZXVWlAMrCNR2o7_MUekCjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药时代知识宝库｜趁着双12，快来薅药时代知识宝库羊毛！</title>
    <updated>2020-12-09T08:12:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/srsGP1t9vfB10PpY0bu52Q</id>
    <link href="https://mp.weixin.qq.com/s/srsGP1t9vfB10PpY0bu52Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>君圣泰完成数千万美元B+轮融资，加速推进原创新药多个适应症临床II/III期的全球同步开发，并启动新适应症及新品种的临床研究</title>
    <updated>2020-12-08T08:00:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/rnVjJSNFR7gnaUt3aZB04A</id>
    <link href="https://mp.weixin.qq.com/s/rnVjJSNFR7gnaUt3aZB04A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH｜功能性治愈潜力显现，CTX001基因疗法能否在未来大放异彩？</title>
    <updated>2020-12-08T08:00:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/zXvZczQYV8q982tIwcVw5g</id>
    <link href="https://mp.weixin.qq.com/s/zXvZczQYV8q982tIwcVw5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>